Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Breast Cancer Health Center

Font Size

FDA Approves New Use for Breast Cancer Drug

Aromasin May Now Treat Early Breast Cancer in Postmenopausal Women
WebMD Health News

Oct. 6, 2005 -- The FDA has approved a new use of the breast cancer drug Aromasin.

Aromasin, an aromatase inhibitor, may now be used to treat early breast cancer in postmenopausal women with estrogen-sensitive breast cancer who have already taken another breast cancer drug, tamoxifen, for two to three years.

That would give those women a total of five consecutive years of hormone therapy treatment after breast cancer treatment (starting with tamoxifen and ending with Aromasin).

Breast cancer is women's most common cancer, except for nonmelanoma skin cancers. More women are surviving breast cancer. Of course, it's still a must to see a doctor for any breast concerns and to get recommended breast cancer screening, even if you feel fine.

According to the American Cancer Society, there are more than 2 million breast cancer survivors in the U.S. (some of them are men). Lung cancer is women's No. 1 cause of cancer deaths.

New Use for Aromasin

Aromasin is not a brand-new drug. It was approved in the U.S. in 1999 to treat advanced breast cancer in postmenopausal women whose tumors have stopped responding to tamoxifen.

Other medications like Aromasin include the aromatase inhibitors Arimidex, and Femara. They are used in postmenopausal women with estrogen-sensitive breast cancer and lower the amount of estrogen that is in the body, which can make these breast cancers grow.

Femara is made by Novartis. Arimidex is made by AstraZeneca. Both companies are WebMD sponsors.

The original approval of Aromasin remains in place. The FDA's latest decision just extends Aromasin's approval to postmenopausal women with early breast cancer following two to three years of tamoxifen.

Aromasin should not be taken by premenopausal women and women who are pregnant, states Pfizer, the maker of Aromasin. Pfizer is a WebMD sponsor.

Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
Breast Cancer Treatments Improving
Resolved To Quit Smoking
Woman getting mammogram
Screening Tests for Women
ovarian cancer overview slideshow
serious woman
what is your cancer risk
10 Ways to Revitalize Slideshow